LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0016667
 42.81 27.76 2261 3596 0.6287 0.8720
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 44.52 27.76 2400 3884 0.6179 0.8694
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 46.22 27.76 2548 4125 0.6177 0.8708
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 46.22 27.76 2568 4125 0.6226 0.8729
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 49.63 27.76 2818 4818 0.5849 0.8609
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 51.33 27.76 2931 5117 0.5728 0.8573
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 53.04 27.76 3023 5365 0.5634 0.8545
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 53.04 27.76 3041 5365 0.5668 0.8559
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 56.45 27.76 3327 5745 0.5791 0.8629
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 56.45 27.76 3346 5745 0.5824 0.8643
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 58.15 27.76 3469 5906 0.5873 0.8670
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 59.85 27.76 3603 6062 0.5943 0.8705
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 1.95 27.76 620 225 2.7538 1.7971
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 3.66 27.76 663 283 2.3351 1.5753
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 5.36 27.76 3 320 0.0094 -0.4677
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 7.06 27.76 815 360 2.2639 1.4947
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 8.76 27.76 36 401 0.0897 0.0698
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 10.46 27.76 96 438 0.2189 0.3656
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 10.46 27.76 933 438 2.1270 1.4174
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 13.87 27.76 1056 604 1.7463 1.2672
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 15.58 27.76 963 685 1.4047 1.1524
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 17.28 27.76 1083 838 1.2913 1.1067
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 64.97 27.76 3992 6656 0.5997 0.8747
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 63.26 27.76 3858 6465 0.5967 0.8729
MN20160318_Q01
C03